TORONTO, ONTARIO--(Marketwire - March 14, 2012) - EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) ("EasyMed" or the "Company"), a leading provider of mobile technology solutions for the healthcare industry, reported today that the Company has entered into an agreement with Medspazio (WDS Technologies SA) one of the largest providers of radiology clinic management software in Switzerland with over 80 customer system deployments.
The new solution will integrate EasyMed SmartCare's mobile software with Medspazio radiology clinic management software enhancing patient pre-visit and post-visit customer satisfaction. The new joint offering will strengthen Medspazio's already market leading position resulting in end-to-end patient care through connection via their mobile phones.
The parties have successfully deployed the new joint solution in IIM clinic, one the largest radiology clinics in Geneva. It is the intention of both parties to deploy the new solution to all 80 Medspazio's existing clients and to sell the joint product to new clients globally.
EasyMed's CEO Andrew Ritchie commented, "We are delighted about this new partnership because Medspazio has a very large existing customer base and our new joint offering is a win-win for both companies as well as Medspazio's clients and their patients. We also believe that there is a huge potential global market for our new affordable joint solution and is a natural upgrade to Medspazio's existing installations."
About EasyMed Services, Inc.
EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) is a global medical information technology company delivering an end to end patient care solution through mobile phone/PDA and server technologies offering specialized services and applications for healthcare, insurance and pharmaceutical industries. We are committed to world-class customer service and the protection of our clients' information.
For more information, visit www.easymedservices.com.
WDS Technologies was founded in 1985 by Dr med dipl. Ing Ronald Welz. The house was from the beginning high-tech and software oriented. Among the most relevant developments, WDS Technologies has developed for Logitech International Inc. leading products on the market (PC peripheral device software), paging systems and financial information systems. Since 1994, WDS Technologies has entered the medical imaging field and has based its strategy on close cooperation with research institutes (University Hospital of Geneva, Digital Imaging Unit, Prof Ratib and the Swiss Federal Institute of Technology, Prof Hersch, Lausanne), manufacturers and local integrators in Europe. WDS Technologies has close contact with various international institutions working in the medical imaging, Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) fields. As such, WDS Technologies acquired significant experience, in particular, in image visualization, processing, distribution and archiving. Since 1997, WDS Technologies is a shareholder company. In order to benefit from the boosting technical possibilities and the low cost of the industrial PC-platform, WDS Technologies exclusively develops PC based applications. WDS Technologies supports and encourages the use of the European and American DICOM 3 standard.
This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. These forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances.The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.